Patents by Inventor Nima Badie
Nima Badie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12290692Abstract: Described herein are methods for use with an implantable system including at least an atrial leadless pacemaker (aLP). Also described herein are specific implementations of an aLP, as well as implantable systems including an aLP. In certain embodiments, the aLP senses a signal from which cardiac activity associated with a ventricular chamber can be detected by the aLP itself based on feature(s) of the sensed signal. The aLP monitors the sensed signal for an intrinsic or paced ventricular activation within a ventricular event monitor window. In response to the aLP detecting an intrinsic or paced ventricular activation itself from the sensed signal within the ventricular event monitor window, the aLP resets an atrial escape interval timer that is used by the aLP to time delivery of an atrial pacing pulse if an intrinsic atrial activation is not detected within an atrial escape interval.Type: GrantFiled: February 13, 2024Date of Patent: May 6, 2025Assignee: Pacesetter, Inc.Inventors: Xiaoyi Min, Weiqun Yang, Benjamin T. Persson, Nima Badie, Kyungmoo Ryu, Gabriel Mouchawar
-
Patent number: 12285617Abstract: Embodiments describe herein generally pertain to implantable medical device (IMDs), and methods for use therewith, that can be used to automatically switch an IMD from its normal operational mode to magnetic resonance imaging (MRI) safe mode, and vice versa, within increased specificity. A controller of an IMD is configured to use an accelerometer to determine whether a positional condition associated with a patient is detected, and control sampling of a magnetic field sensor or at least one signal output therefrom, such that a first sampling rate is used when the positional condition is detected, and a second sampling rate, that is slower than the first sampling rate, is used when the positional condition is not detected, to thereby conserve power. Based on results of the sampling, the controller determines whether a magnetic field condition is detected, and in response thereto performs a mode switch to an MRI safe mode.Type: GrantFiled: July 18, 2022Date of Patent: April 29, 2025Assignee: Pacesetter, Inc.Inventors: Xing Pei, Brad Lindevig, Stuart Rosenberg, Nima Badie
-
Publication number: 20250099771Abstract: A system includes, or is for use with, an atrial leadless pacemaker (aLP) and a ventricular leadless pacemaker (vLP) configured to communicate with one another and collectively provide DDD operation when an a2v message transmitted by the aLP is successfully received by the vLP and a v2a message transmitted by the vLP is successfully received by the aLP, during a cardiac cycle. The aLP and the vLP are also configured to collectively provide VDD operation, DDI operation or VDI operation at least some times when an a2v message transmitted by the aLP is not successfully received by the vLP, and/or a v2a message transmitted by the vLP is not successfully received by the aLP. One or more processors of the system is/are configured to determine an AV synchrony metric for the period of time, and provide one or more responses based thereon. Related methods are also described.Type: ApplicationFiled: August 15, 2024Publication date: March 27, 2025Applicant: Pacesetter, Inc.Inventors: Aditya Goil, Nima Badie, Daniel F. Booth
-
Patent number: 12257440Abstract: A system and method are provided for managing atrial-ventricular (AV) delay adjustments. An AV interval is measured that corresponds to an interval between an atrial paced (Ap) event or an atrial sensed (As) event and a sensed ventricular (Vs) event. A candidate AV delay is set based on the AV interval and a bundle branch adjustment (BBA) value. A QRS characteristic of interest (COI) is measured while utilizing the candidate AV delay in connection with delivering a pacing therapy. The BBA value is adjusted and the candidate AV delay is reset based on the BBA value as adjusted. A collection of QRS COIs and corresponding candidate AV delays are obtained and one of the candidate AV delays is selected as a BBA AV delay. The pacing therapy is managed, based on the BBA AV delay.Type: GrantFiled: April 10, 2023Date of Patent: March 25, 2025Assignee: Pacesetter, Inc.Inventors: Wenwen Li, Nima Badie, Luke C. McSpadden, Yun Qiao, Avi Fischer, Kyungmoo Ryu
-
Publication number: 20250082274Abstract: Embodiments reduce burden associated with analyzing EGM segments obtained from an IMD that monitors for arrhythmic episodes. Respective EGM data and respective classification data is obtained for each arrhythmic episode detected by the IMD during a period of time. A representative R-R interval or HR for each of the arrhythmic episodes is determine by the IMD, wherein a manner for determining the representative R-R interval or HR depends on the type of the arrhythmic episode, such that for at least two different types of arrhythmic episodes the manners differ. An external system(ES) obtains data from the IMD, directly or indirectly, and selects arrhythmic episode(s) for which corresponding EGM segments are to be displayed for each type of arrhythmic episode, wherein the selecting is performed based on the representative R-R intervals or HRs determined by the IMD for the arrhythmic episodes. Additional and alternative embodiments are also described herein.Type: ApplicationFiled: November 26, 2024Publication date: March 13, 2025Applicant: Pacesetter, Inc.Inventors: Nima Badie, Fujian Qu, Leyla Sabet, Fady Dawoud, Kevin Davis, Christopher Gloschat, Aditya Goil, Mostafa Sadeghi
-
Publication number: 20250032032Abstract: Described herein are methods, devices, and systems for identifying false R-R intervals, and false arrhythmia detections, resulting from R-wave undersensing or intermittent AV conduction block. Each of one or more of the R-R intervals is classified as being a false R-R interval in response to a duration the R-R interval being greater than a first specific threshold, and the duration the R-R interval being within a second specified threshold of being an integer multiple of at least X other R-R intervals for which information is obtained, wherein the integer multiple is at least 2, and wherein X is a specified integer that is 1 or greater. When performed for R-R intervals in a window leading up to a detection of a potential arrhythmic episode, results of the classifying can be used to determine whether the potential arrhythmic episode was a false positive detection.Type: ApplicationFiled: October 17, 2024Publication date: January 30, 2025Applicant: Pacesetter, Inc.Inventors: Nima Badie, Fujian Qu, Jong Gill
-
Publication number: 20250018197Abstract: A system and method have at least one implantable lead comprising a right ventricular (RV) electrode and one or more left ventricular (LV) electrodes, at least one processor, and a memory coupled to the at least one processor. The memory stores program instructions.Type: ApplicationFiled: October 1, 2024Publication date: January 16, 2025Inventors: Jan O. Mangual-Soto, Nima Badie, Luke C. McSpadden
-
Patent number: 12186100Abstract: Embodiments described herein can reduce a burden associated with analyzing EGM segments obtained from an IMD that monitors for arrhythmic episodes. Respective EGM data and respective classification data is obtained for each arrhythmic episode detected by the IMD during a period of time. A representative R-R interval or HR for each of the arrhythmic episodes is also obtained, wherein a manner for determining the representative R-R interval or HR depends on the type of the arrhythmic episode, such that for at least two different types of arrhythmic episodes the manners differ. One or more arrhythmic episodes is/are selected for which corresponding EGM segments are to be displayed for each type of arrhythmic episode, wherein the selecting is performed based on the representative R-R intervals or HRs that are determined for the plurality of arrhythmic episodes. Additional and alternative embodiments are also described herein.Type: GrantFiled: May 6, 2022Date of Patent: January 7, 2025Assignee: Pacesetter, Inc.Inventors: Nima Badie, Fujian Qu, Leyla Sabet, Fady Dawoud, Kevin Davis, Christopher Gloschat, Aditya Goil, Mostafa Sadeghi
-
Patent number: 12161474Abstract: Described herein are methods, devices, and systems for identifying false R-R intervals, and false arrhythmia detections, resulting from R-wave undersensing or intermittent AV conduction block. Each of one or more of the R-R intervals is classified as being a false R-R interval in response to a duration the R-R interval being greater than a first specific threshold, and the duration the R-R interval being within a second specified threshold of being an integer multiple of at least X other R-R intervals for which information is obtained, wherein the integer multiple is at least 2, and wherein X is a specified integer that is 1 or greater. When performed for R-R intervals in a window leading up to a detection of a potential arrhythmic episode, results of the classifying can be used to determine whether the potential arrhythmic episode was a false positive detection.Type: GrantFiled: May 13, 2021Date of Patent: December 10, 2024Assignee: Pacesetter, Inc.Inventors: Nima Badie, Fujian Qu, Jong Gill
-
Publication number: 20240399156Abstract: Diurnal and nocturnal pacing for an implantable medical device (IMD) that includes a temperature sensor, one or more electrodes, one or more pulse generators and a control circuit is managed. A temperature signal indicative of a core body temperature is sensed at the temperature sensor. The control circuit produces first and second moving composite temperature (MCT) signals based on the temperature signal sensed over first and second periods of time, respectively, wherein the second period of time is longer than the first period of time. A current temperature signal is compared to the first and second MCT signals, and a pacing rate for pacing pulses, generated by the one or more pulse generators and delivered to the one or more electrodes, is controlled based on one or more relations between the current temperature signal, the first MCT signal and the second MCT signal.Type: ApplicationFiled: May 14, 2024Publication date: December 5, 2024Inventors: Daniel F. Booth, Nima Badie, Donald Chin
-
Patent number: 12150770Abstract: Described herein are methods, devices, and systems that improve arrhythmia episode detection specificity, such as, but not limited to, atrial fibrillation (AF) episode detection specificity. Such a method can include obtaining an ordered list of R-R intervals within a window leading up to a detection of a potential arrhythmia episode, determining a measure of a dominant repeated R-R interval pattern within the window, and comparing the measure of the dominant repeated R-R interval pattern to a pattern threshold. If the measure of the dominant repeated R-R interval pattern is below the pattern threshold, that is indicative of a regularly irregular pattern being present, and there is a determination that the detection of the potential arrhythmia episode does not correspond to an actual arrhythmia episode. Such embodiments can beneficially be used to significantly reduce the number of false positive arrhythmia detections.Type: GrantFiled: March 28, 2023Date of Patent: November 26, 2024Assignee: Pacesetter, Inc.Inventors: Nima Badie, Fujian Qu, Jong Gill
-
Patent number: 12128240Abstract: A system and method have at least one implantable lead comprising a right ventricular (RV) electrode and one or more left ventricular (LV) electrodes, at least one processor, and a memory coupled to the at least one processor. The memory stores program instructions.Type: GrantFiled: January 28, 2022Date of Patent: October 29, 2024Assignee: Pacesetter, Inc.Inventors: Jan O. Mangual-Soto, Nima Badie, Luke C. McSpadden
-
Publication number: 20240341662Abstract: Described herein are methods, devices, and systems that monitor heart rate and/or for arrhythmic episodes based on sensed intervals that can include true R-R intervals as well as over-sensed R-R intervals. True R-R intervals are initially identified from an ordered list of the sensed intervals by comparing individual sensed intervals to a sum of an immediately preceding two intervals, and/or an immediately following two intervals. True R-R intervals are also identified by comparing sensed intervals to a mean or median of durations of sensed intervals already identified as true R-R intervals. Individual intervals in a remaining ordered list of sensed intervals (from which true R-R intervals have been removed) are classified as either a short interval or a long interval, and over-sensed R-R intervals are identified based on the results thereof. Such embodiments can be used, e.g., to reduce the reporting of and/or inappropriate responses to false positive tachycardia detections.Type: ApplicationFiled: June 17, 2024Publication date: October 17, 2024Applicant: Pacesetter, Inc.Inventors: Nima Badie, Fujian Qu, Jong Gill
-
Publication number: 20240315731Abstract: Disclosed herein is a catheter for delivering an implantable medical lead to an implantation site near an ostium leading to a proximal region of a coronary sinus. The catheter includes a distal end, a proximal end opposite the distal end, a tubular body extending between the distal and proximal ends, an atraumatic fixation structure defining a distal termination of the distal end, and a lead receiving lumen. The atraumatic fixation structure is configured to enter the ostium and passively pivotally anchor with the proximal region of the coronary sinus. The lead receiving lumen extends along the tubular body from the proximal end to an opening defined in a side of the tubular body near the distal end and proximal the atraumatic fixation structure.Type: ApplicationFiled: June 5, 2024Publication date: September 26, 2024Inventors: Wenwen Li, Gene A. Bornzin, Didier Theret, Luke C. McSpadden, Nima Badie
-
Publication number: 20240268687Abstract: A controller is provided for calibrating an implantable pressure sensor. The controller includes an implantable pressure sensor configured to obtain characteristics of interest related to a patient, one or more processors, and a memory coupled to the one or more processors, wherein the memory stores program instructions. The program instructions are executable by the one or more processors to determine an implantable pressure sensor parameter in real time based on the characteristics of interest related to the patient and provide a drift threshold related to the implantable pressure sensor parameter. The one or more processors are also configured to determine whether the drift threshold has been exceeded based on the implantable pressure sensor parameter and communicate an alert in response to determining the drift threshold has been exceeded.Type: ApplicationFiled: December 28, 2023Publication date: August 15, 2024Inventors: Vahid Sadri, Nima Badie, Michael Fonseca, Jason White, John Erik Moore
-
Publication number: 20240252827Abstract: An implantable medical device (IMD) and process are provided comprising one or more electrodes configured to be implanted to define a pacing vector through at least a portion of a ventricle. Sensing circuitry is configured to sense intrinsic atrial activity (As) and intrinsic ventricular activity (Vs). A pulse generator (PG) if provided, and memory configured to store program instructions and an atrioventricular delay search parameter (AVDSEARCH). The AVDSEARCH is an interval of time. One or more processors, that when executing the program instructions, is configured to direct the PG to deliver ventricular pacing pulses based on an atrioventricular delay (AVD) and periodically initiate an AVD search operation utilizing the AVDSEARCH. A heart rate is determined and compared to a threshold. Responsive to determining that the heart rate exceeds the threshold, the AVDSEARCH is reduced, and cardiac activity is detected during the AVD search operation utilizing the reduced AVDSEARCH.Type: ApplicationFiled: December 18, 2023Publication date: August 1, 2024Inventors: Nima Badie, Aditya Goil, Kunal Chaniary
-
Patent number: 12042292Abstract: Described herein are methods, devices, and systems that monitor heart rate and/or for arrhythmic episodes based on sensed intervals that can include true R-R intervals as well as over-sensed R-R intervals. True R-R intervals are initially identified from an ordered list of the sensed intervals by comparing individual sensed intervals to a sum of an immediately preceding two intervals, and/or an immediately following two intervals. True R-R intervals are also identified by comparing sensed intervals to a mean or median of durations of sensed intervals already identified as true R-R intervals. Individual intervals in a remaining ordered list of sensed intervals (from which true R-R intervals have been removed) are classified as either a short interval or a long interval, and over-sensed R-R intervals are identified based on the results thereof. Such embodiments can be used, e.g., to reduce the reporting of and/or inappropriate responses to false positive tachycardia detections.Type: GrantFiled: December 27, 2022Date of Patent: July 23, 2024Assignee: Pacesetter, Inc.Inventors: Nima Badie, Fujian Qu, Jong Gill
-
Patent number: 12004775Abstract: Disclosed herein is a catheter for delivering an implantable medical lead to an implantation site near an ostium leading to a proximal region of a coronary sinus. The catheter includes a distal end, a proximal end opposite the distal end, a tubular body extending between the distal and proximal ends, an atraumatic fixation structure defining a distal termination of the distal end, and a lead receiving lumen. The atraumatic fixation structure is configured to enter the ostium and passively pivotally anchor with the proximal region of the coronary sinus. The lead receiving lumen extends along the tubular body from the proximal end to an opening defined in a side of the tubular body near the distal end and proximal the atraumatic fixation structure.Type: GrantFiled: October 15, 2020Date of Patent: June 11, 2024Assignee: PACESETTER, INC.Inventors: Wenwen Li, Gene A. Bornzin, Didier Theret, Luke C. McSpadden, Nima Badie
-
Publication number: 20240181265Abstract: Described herein are methods for use with an implantable system including at least an atrial leadless pacemaker (aLP). Also described herein are specific implementations of an aLP, as well as implantable systems including an aLP. In certain embodiments, the aLP senses a signal from which cardiac activity associated with a ventricular chamber can be detected by the aLP itself based on feature(s) of the sensed signal. The aLP monitors the sensed signal for an intrinsic or paced ventricular activation within a ventricular event monitor window. In response to the aLP detecting an intrinsic or paced ventricular activation itself from the sensed signal within the ventricular event monitor window, the aLP resets an atrial escape interval timer that is used by the aLP to time delivery of an atrial pacing pulse if an intrinsic atrial activation is not detected within an atrial escape interval.Type: ApplicationFiled: February 13, 2024Publication date: June 6, 2024Applicant: Pacesetter, Inc.Inventors: Xiaoyi Min, Weiqun Yang, Benjamin T. Persson, Nima Badie, Kyungmoo Ryu, Gabriel Mouchawar
-
Publication number: 20240099641Abstract: A computer implemented method for detecting arrhythmias in cardiac activity including obtaining far field cardiac activity (CA) signals for a series of beats. For at least a portion of the beats, the one or more processors perform, on a beat by beat basis: a) identifying first and second feature of interests (FOI) from a segment of the CA signal that corresponds to a current beat; and b) classifying the current beat into one of first and second groups. The method also includes designating one of the first and second groups to be a primary group based on a relation between the first and second groups, and for the beats in the primary group, selecting one of the first and second FOIs as the R-wave FOI. The method also includes rejecting an arrhythmia detection based on the P-waves detected.Type: ApplicationFiled: December 6, 2023Publication date: March 28, 2024Inventors: Fujian Qu, Nima Badie, Jong Gill